XML 92 R79.htm IDEA: XBRL DOCUMENT v3.22.0.1
Selected Quarterly Financial Information - Summary of Company's Selected Quarterly Financial Information (Detail) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Quarterly Financial Information Disclosure [Abstract]      
Net revenue $ 1,911,191 $ 1,733,951 $ 1,779,759
Practice salaries and benefits 1,297,477 1,193,940 1,180,759
Practice supplies and other operating expenses 100,472 90,690 95,911
General and administrative expenses 263,357 248,947 244,512
Gain on sale of building (7,280)
Depreciation and amortization 32,147 28,441 25,931
Transformational and restructuring related expenses 22,100 73,801 60,890
Total operating expenses 1,708,273 1,635,819 1,608,003
Income from operations 202,918 98,132 171,756
Investment and other (expense) income 13,652 17,913 3,686
Interest expense (68,722) (110,482) (118,928)
Loss on early extinguishment of debt (14,532)
Equity in earnings of unconsolidated affiliates 1,912 1,585 2,270
Total non-operating expenses (67,690) (90,984) (112,972)
(Loss) income from continuing operations before income taxes 135,228 7,148 58,784
Income tax benefit (provision) (27,241) (16,728) (16,576)
Income (loss) from continuing operations 107,987 (9,580) 42,208
(Loss) income from discontinued operations, net of tax 22,950 (786,908) (1,539,910)
Net income (loss) 130,937 (796,488) (1,497,702)
Net income (loss) attributable to Mednax, Inc. $ 130,964 $ (796,488) $ (1,497,702)
Income from continuing operations, Basic $ 1.27 $ (0.11) $ 0.50
Income from continuing operations, Diluted 1.26 (0.11) 0.50
Loss from discontinued operations, Basic 0.27 (9.44) (18.44)
Loss from discontinued operations, Diluted 0.27 (9.44) (18.33)
Earnings Per Share, Basic 1.54 (9.55) (17.94)
Earnings Per Share, Diluted $ 1.53 $ (9.55) $ (17.83)
Weighted Average Number of Shares Outstanding, Basic 84,832 83,395 83,495
Weighted average shares, Diluted 85,828 83,395 84,011